ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3163

SEC16A and Intracellular Trafficking Abnormalities in Axial Spondyloarthritis

Fanxing Zeng1, Zhenbo Zhang1, Vidya Ranganathan2, Darren Orielly3, Proton Rahman4 and Nigil Haroon5, 1Krembil research institute, Toronto, ON, Canada, 2University Health Network, Toronto, ON, Canada, 3Faculty of Medicine, Memorial University of Newfoundland, St. John’s, NF, Canada, 4Rheumatology, St Claires Mercy Hospital, St Johns, NF, Canada, 5Rheumatology, Toronto Western Hospital, University of Toronto, Spondylitis Clinic, Toronto, ON, Canada

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: ankylosing spondylitis (AS) and human leukocyte antigens (HLA), B cells, ER Stress

  • Tweet
  • Email
  • Print
Session Information

Date: Wednesday, November 16, 2016

Title: Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology II

Session Type: ACR Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: The pathogenesis of Axial Spondyloarthritis (AxSpA) is not well understood. A rare 9 base-pair deletion of SEC16A was recently identified to be strongly associated with AxSpA in a multiplex family. SEC16A plays an important role in endoplasmic reticulum (ER)-to-Golgi transport and the assembly of cargo carrier vesicles. We investigated if variations in SEC16A could affect the ER-Golgi transport of HLA-B27 and influence AxSpA pathogenesis.

Methods: EBV transformed B cells were isolated from 14 HLA-B27 positive members of the multiplex family. Out of 9 members with the SEC16A 9 bp deletion, 8 have been diagnosed with AxSpA and one 16-year-old was healthy. Five healthy family members had the wild-type (WT) SEC16A. C1R-B27 cells (B-lymphoblastoid cells with stable HLA-B27 expression) were used to replicate findings by knocking out (KO) SEC16A using CRISPR. Fluorescent tagged monoclonal antibodies against SEC16A and SEC31A (identifies ER-to-Golgi transport vesicle COPII) were used. The formation of ER-to-Golgi transport vesicles and the organization of ER exit sites (ERES) were studied using confocal microscopy. The vesicular stomatitis virus glycoprotein (VSVG-GFP) was used to track ER-to-Golgi transport. In addition, Fluorescence Recovery After Photobleaching (FRAP) was performed to study the dynamics of ER-to-Golgi transport vesicles. Changes in surface and intracellular HLA-B27 and free heavy chain (FHC) expression were tested by flow cytometry. Activation of unfolded protein response (UPR) was measured using PCR and western blot for BiP, CHOP and ATF-6.

Results: EBV-B cells with the SEC16A mutation had a significantly (P<0.001) lower number of secretory vesicles at ERES (co-localization of SEC16A and SEC31A in Figure 1A) and impaired ER-to-Golgi transport (decreased VSVG-GFP trafficking). By FRAP, there was poor recruitment of SEC31A to ERES. There was significantly lower surface expression of intact HLA-B27 and FHC (P<0.01) and accumulation of both intracellularly (P<0.01). All findings were replicated in C1R-B27 cells after 90 % SEC16A suppression. UPR was significantly elevated due to the insufficient ER-Golgi transport in the SEC16A knock out C1R-B27 cells (Figure 1B).

Conclusion: Thus SEC16A is an important factor that can influence HLA-B27 trafficking, surface and intracellular expression and UPR. Abnormal SEC16A-HLA-B27 interaction may play an important role in the pathogenesis of AxSpA. Figure 1. A 9-bp deletion of SEC16A (MUT) decreases COPII vesicle formation compared to wild Type SEC16A (WT) (A). SEC16A knockout (90%) leads to increased unfolded protein response (B).      


Disclosure: F. Zeng, None; Z. Zhang, None; V. Ranganathan, None; D. Orielly, None; P. Rahman, Janssen Inc., 5; N. Haroon, None.

To cite this abstract in AMA style:

Zeng F, Zhang Z, Ranganathan V, Orielly D, Rahman P, Haroon N. SEC16A and Intracellular Trafficking Abnormalities in Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/sec16a-and-intracellular-trafficking-abnormalities-in-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sec16a-and-intracellular-trafficking-abnormalities-in-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology